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The American Heart Association Ideal Cardiovascular Health
and Incident Type 2 Diabetes Mellitus Among Blacks:
The Jackson Heart Study
Valery S. Effoe, MD, MS; Mercedes R. Carnethon, PhD, MSPH; Justin B. Echouffo-Tcheugui, MD, PhD; Haiying Chen, PhD;
Joshua J. Joseph, MD; Arnita F. Norwood, PhD, MPH, RD; Alain G. Bertoni, MD, MPH
Background-—The concept of ideal cardiovascular health (CVH), deﬁned by the American Heart Association primarily for coronary
heart disease and stroke prevention, may apply to diabetes mellitus prevention among blacks.
Methods and Results-—Our sample included 2668 adults in the Jackson Heart Study with complete baseline data on 6 of 7
American Heart Association CVH metrics (body mass index, healthy diet, smoking, total cholesterol, blood pressure, and physical
activity). Incident diabetes mellitus was deﬁned as fasting glucose ≥126 mg/dL, physician diagnosis, use of diabetes mellitus
drugs, or glycosylated hemoglobin ≥6.5%. A summary CVH score from 0 to 6, based on presence/absence of ideal CVH metrics,
was derived for each participant. Cox regression was used to estimate adjusted hazard ratios. Mean age was 55 years (65%
women) with 492 incident diabetes mellitus events over 7.6 years (24.6 cases/1000 person-years). Three quarters of participants
had only 1 or 2 ideal CVH metrics; no participant had all 6. After adjustment for demographic factors (age, sex, education, and
income) and high-sensitivity C-reactive protein, each additional ideal CVH metric was associated with a 17% diabetes mellitus risk
reduction (hazard ratio, 0.83; 95% CI, 0.74–0.93). The association was attenuated with further adjustment for homeostasis model
assessment for insulin resistance (hazard ratio, 0.89; 95% CI, 0.79–1.00). Compared with participants with 1 or no ideal CVH
metric, diabetes mellitus risk was 15% and 37% lower in those with 2 and ≥3 ideal CVH metrics, respectively.
Conclusions-—The AHA concept of ideal CVH is applicable to diabetes mellitus prevention among blacks. These associations were
largely explained by insulin resistance. ( J Am Heart Assoc. 2017;6:e005008. DOI: 10.1161/JAHA.116.005008.)
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B lacks have a disproportionately higher risk of type 2diabetes mellitus and higher rates of diabetes mellitus–
related complications and death than non-Hispanic whites.1
Overweight and obesity, fasting hyperglycemia, physical
inactivity, and poor dietary habits are important modiﬁable
risk factors for the development of diabetes mellitus, and
interventions targeting these factors have been shown to
delay or prevent the development of diabetes mellitus.2–5
Based on evidence on the role of 7 modiﬁable cardiovascular
health (CVH) factors and behaviors (smoking, total choles-
terol, fasting glucose, body mass index [BMI], healthy diet,
blood pressure, and physical activity), the American Heart
Association (AHA) deﬁned the concept of ideal CVH as part of
efforts to decrease cardiovascular disease (CVD) and stroke
incidence and mortality.6 Given the commonality in risk
factors between CVD and diabetes mellitus, the concept of
ideal CVH may be applicable to the primordial and primary
prevention of diabetes mellitus.
Fewer Americans, particularly blacks, achieve ideal CVH,
especially for BMI, physical activity, and healthy diet, which
have been strongly associated with incident diabetes
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mellitus.7–9 The association between AHA-deﬁned ideal CVH
and the development of diabetes mellitus is less clear among
blacks than among other race-ethnic groups. Fretts et al,
using data on American Indians from the SHFS (Strong Heart
Family Study), showed that having at least 2 AHA-deﬁned
ideal CVH metrics, compared with 1 or none, signiﬁcantly
reduced the odds of developing diabetes mellitus.10 In MESA
(Multi-Ethnic Study of Atherosclerosis),11 participants with 2
to 3 and 4 or more ideal CVH metrics had a 34% and 75%
lower risk of incident diabetes mellitus, respectively. In MESA,
the association between ideal CVH and diabetes mellitus was
less robust among blacks and Hispanics compared with
whites and Chinese.11 Among blacks, though there was a
signiﬁcant trend in diabetes mellitus risk reduction with
increasing number of ideal CVH metrics, there was no
apparent association between each level of ideal CVH metric
and the referent group (no ideal CVH metric). This lack of
association could be attributed, in large part, to insufﬁcient
power in the stratiﬁed analysis. The MESA study and JHS
(Jackson Heart Study) recruited blacks from different geo-
graphical regions in the United States. The JHS is a single-site
study and recruited all blacks from Jackson, Mississippi, a
state with the highest rates of diabetes mellitus in the
nation.12 In contrast, blacks in the MESA study were recruited
primarily from Maryland and North Carolina, and to a lesser
extent New York, California, and Illinois. The JHS enrolled
more blacks, and there are more incident cases of diabetes
mellitus among blacks in the JHS than in MESA, and, as such,
the JHS is well powered to address this question.
If ideal CVH, as deﬁned by the AHA, is applicable to
diabetes mellitus prevention among blacks, future joint efforts
for CVD and diabetes mellitus prevention in this population
may provide 1 effective and cost-efﬁcient strategy for public
health experts and policy makers to tackle the growing
challenge of diabetes mellitus and CVD. To investigate this
further, we examined the association between AHA-deﬁned
ideal CVH and incident diabetes mellitus in the JHS, a large
cohort of blacks. Speciﬁcally, we sought to determine whether
there was a graded relationship between increasing number of
ideal CVH metrics and diabetes mellitus risk reduction, and
the role insulin resistance plays in this association. We
hypothesized that increasing number of ideal CVH metrics will
be signiﬁcantly associated with a lower incidence of diabetes
mellitus.
Methods
Study Sample
The JHS enrolled 5301 participants aged 21 to 94 years at the
time of the baseline assessment (2000–2004) from the
Jackson, Mississippi, metropolitan area. The goal of the study
was to examine factors that inﬂuence the development of
CVD in black men and women to learn how to prevent this
group of diseases in this population. Two subsequent in-
person follow-up visits have been completed since baseline
(2005–2008 and 2009–2013). Details about the study design
and recruitment process have been published.13,14
Data Collection
Baseline information, including demographics, socioeconomic
status, lifestyle data, and medication use, was obtained by
study personnel through interviews during clinic visits or at
home. Medication use in the 2 weeks preceding each clinic
visit was assessed at the time of the clinic visit. Blood
samples were collected according to standard procedures and
metabolic variables (glucose, insulin, and lipids) were analyzed
at a central laboratory (University of Minnesota).15
Ascertainment of Incident Type 2 Diabetes
Mellitus
At baseline, fasting plasma glucose was measured by the
glucose oxidase colorimetric method using a Vitros 950 or
250 (Ortho Clinical Diagnostics analyzer; Ortho Clinical
Diagnostics, Raritan, NJ), and at visits 2 and 3, it was
measured using a Roche Modular P Chemistry analyzer
Clinical Perspective
What is New?
• Our ﬁndings show a robust association between the
American Heart Association–deﬁned ideal cardiovascular
health (CVH; healthy body mass index, healthy diet,
nonsmoking status, normal total cholesterol, normal blood
pressure, and physical activity) and diabetes mellitus risk
reduction among middle-aged blacks.
• This association is driven, in large part, by insulin resistance.
• The effects of the ideal CVH metrics on reducing diabetes
mellitus risk may be cumulative and synergistic.
What are the Clinical Implications?
• To prevent 1 case of diabetes mellitus in the population, it
would require 55 people to meet 3 American Heart
Association ideal CVH targets and 49 people to meet 4 or
more targets.
• Primary care interventions with a focus on improving health
behaviors so that more blacks achieve the American Heart
Association targets for ideal CVH may have a signiﬁcant
impact in reducing diabetes mellitus risk.
• For clinicians, encouraging their patients to meet these
American Heart Association ideal CVH targets could repre-
sent a great step forward in preventing diabetes mellitus.
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(Roche Diagnostics, Indianapolis, IN). Glycated hemoglobin
was measured using a Tosoh high-performance liquid chro-
matography system (Tosoh Corporation, Tokyo, Japan). We
deﬁned type 2 diabetes mellitus as having either: (1) fasting
glucose ≥126 mg/dL; (2) glycated hemoglobin ≥6.5%; (3) use
of diabetes mellitus medication; or (4) a physician diagnosis of
the condition. We assessed incident type 2 diabetes mellitus
at follow-up visits 2 and 3. For each incident case of type 2
diabetes mellitus, time to event was considered as midpoint
between last exam without diabetes mellitus and the exam at
which diabetes mellitus developed. For participants who
remained event free, follow-up time was censored at their last
available visit.
AHA’s CVH Metrics
Blood pressure
Resting blood pressure (BP) was measured twice at 5-minute
intervals, the average of which was used in our analysis. Ideal
BP was deﬁned as a systolic BP of <120 mm Hg and a diastolic
BP of <80 mm Hg if untreated; intermediate BP was deﬁned as
a systolic BP of 120 to 139 mm Hg or a diastolic BP of 80 to
89 mm Hg, of if treated to goal; and poor BP was deﬁned as a
systolic BP of ≥140 mm Hg or a diastolic BP ≥90 mm Hg.6
Physical activity
Participants completed an interviewer-administered physical
activity (PA) questionnaire at baseline, modiﬁed from the
Baeke PA survey,16 which was also the parent document for
the ARIC (Atherosclerosis Risk in Communities Study) study’s
survey.17,18 This instrument was identical to the one used
during the Kaiser PA survey, which showed good validity and
reliability in a multiethnic sample.19 Exercise was reported by
the average amount of time per week spent, and metabolic
equivalent levels were deﬁned for each activity. Moderate
activity was deﬁned as 3 to 6 metabolic equivalents and
vigorous activity as >6 metabolic equivalents. Ideal PA was
deﬁned as ≥150 minutes of moderate-intensity activity or
≥75 minutes of vigorous activity or ≥150 minutes of com-
bined moderate-intensity and vigorous activity per week;
intermediate PA was deﬁned as 1 to 149 minutes of
moderate-intensity activity or 1 to 74 minutes of vigorous
activity or 1 to 149 minutes of combined moderate-intensity
and vigorous activity per week; poor PA was deﬁned as no
amount of activity (0 minutes per week).6
Body Mass Index
BMI was determined as weight (in kilograms) divided by the
square of height (in meters). BMI was deﬁned as ideal,
<25 kg/m2; intermediate, 25 to 29.9 kg/m2; and poor,
≥30 kg/m2.6
Smoking
Cigarette smoking was as self-reported and participants were
asked about the quantity and duration of smoking. Ideal
smoking was deﬁned as participants who had never smoked
or who quit smoking more than 12 months preceding the
clinic visit; intermediate was deﬁned as former smokers who
quit smoking within 12 months of the clinic visit; and poor
was deﬁned as a current smoker.6
Total cholesterol
Total cholesterol was measured by the cholesterol oxidase
method (Roche COBAS Fara analyzer; Roche Diagnostics), as
previously described.15 Ideal total cholesterol was deﬁned as a
level of <200 mg/dL if untreated; intermediate total choles-
terol deﬁned by a level of 200 to 239 mg/dL or if treated to
goal; and poor was deﬁned by a level of ≥240 mg/dL.6
Diet
In the JHS, dietary intake was assessed using the Delta NIRI
food frequency questionnaire with 158 items.20,21 The 5
components used to compute the AHA score, based on a
2000-kcal diet, were: (1) ≥4.5 cups daily of fruits and
vegetables; (2) >3.5 ounces, twice per week, of ﬁsh;
(3) <450 kcal per week of sugary beverages; (4) ≥3 daily
servings of whole grains; and (5) <1500 mg daily of sodium.
Ideal diet was deﬁned by a diet including 4 to 5 components;
intermediate diet, 2 to 3 components; and poor diet, 0 to 1
component.6
Measurement of Covariates
Baseline waist circumference was the average of 2 measure-
ments about the umbilicus and in the upright position. Current
alcohol drinking was deﬁned as alcohol use in the past
12 months. Education level was dichotomized as having at
least a college education or higher versus no college education.
Income status was divided into 3 categories based on family
size and income: low income, middle income, and afﬂuent
income groups. Fasting insulin concentration was measured on
a Vitros 950 or 250, Ortho Clinical Diagnostics analyzer (Ortho
Clinical Diagnostics) using standard procedures that met the
College of American Pathologists accreditation requirement.15
Insulin resistance was estimated using the homeostasis model
assessment for insulin resistance (HOMA-IR)=(fasting plasma
insulin [lU/mL])9(fasting plasma glucose [mmol/L])22.5.22
hs-CRP was measured by the immunoturbidimetric CRP-Latex
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assay (Kamiya Biomedical Company, Seattle, WA) using a
Hitachi 911 analyzer (Roche Diagnostics).23
Statistical Analysis
Our analyses were performed using SAS software (version
9.3; SAS Institute Inc, Cary, NC). Using 6 of the 7 AHA health
metrics (BMI, diet, smoking status, BP, total cholesterol, and
PA), for each participant, and for each health metric, presence
of ideal health was scored as 1 and absence as 0. A summary
AHA CVH score was computed ranging from 0 (least ideal
CVH) to 6 (most ideal CVH).
We compared differences in baseline characteristics by
categories of the CVH score using the analysis of variance
test or appropriate nonparametric tests for continuous
variables, and the chi-square test for categorical variables.
Categories of the CVH score were deﬁned based on the
distribution of participants in each score group. Variables with
non-normal distributions were log-transformed as required.
Using Cox regression analysis, we assessed the prospec-
tive graded association between the CVH score (modeled as a
continuous variable) and the risk of incident diabetes mellitus.
Hazard ratios (HRs) for each additional ideal health metric
were estimated. We also examined the association of
categories of the CVH score (≤1, 2, and ≥3) and incident
diabetes mellitus. A sequential modeling approach was used
as follows: model 1 (base model) was unadjusted; model 2
was adjusted for age, sex, education, and income; model 3
was further adjusted for hs-CRP; and model 4 was additionally
adjusted for HOMA-IR.
Because of a previous report of effect modiﬁcation of the
association between low-grade systemic inﬂammation and
incident diabetes mellitus by BMI,24 we also assessed for
interaction by waist circumference in our analysis. Interac-
tions were assessed by including an interaction term in the
regression model. Finally, based on a 5-year risk, we
estimated the number of participants who need to have
increments of the ideal CVH score in order to prevent 1 case
of incident diabetes mellitus. For all analyses, a P value of
≤0.05 was considered statistically signiﬁcant.
Results
After exclusions, our ﬁnal sample size was 2668 adults. The
proportions of participants with an ideal health score of 0, 1,
2, 3, 4, 5, and 6 were 3%, 36.1%, 39.9%, 16.1%, 4.5%, 0.4%,
and 0%, respectively. Table 1 shows baseline characteristics
of participants across categories of the ideal health summary
score; score ≤1 (least ideal), score 2 to 3, and score ≥4 (most
ideal). Compared with participants in the most ideal category,
those in the least ideal category were older, less likely to have
completed college with higher waist circumference, glycated
Table 1. Baseline Characteristics of Participants by Categories of the AHA CVH Score
Characteristic
Categories of AHA CVH Score
P ValueScores ≤1 (n=1042) Score=2 (n=1065) Score ≥3 (n=561)
Age, y 5711 5512 5013 <0.0001
Men, n, % 359 (34.5) 366 (34.4) 198 (35.3) 0.9
Waist circumference, cm 10315 9915 9214 <0.0001
Current alcohol drinker, n, % 467 (45.0) 482 (45.3) 307 (55.1) <0.001
At least college education, n, % 561 (53.8) 660 (62.0) 409 (73.2) <0.0001
Income status, n, %
Low 105 (11.9) 99 (10.9) 50 (10.3) <0.001
Middle 501 (56.6) 477 (52.7) 220 (45.2)
Affluent 279 (31.5) 329 (36.4) 217 (44.6)
Incident diabetes mellitus, n, % 235 (22.6) 191 (17.9) 66 (11.8) <0.0001
Family history of diabetes mellitus, n, % 482 (46.4) 502 (47.3) 232 (41.4) 0.07
Lipid-lowering medication, n, % 157 (17.4) 69 (6.8) 15 (2.7) <0.0001
HOMA-IR* 3.4 (2.3) 3.1 (2.2) 2.5 (1.6) <0.0001
HbA1c, % 5.60.5 5.50.5 5.40.4 <0.0001
hs-CRP*, mg/L 3.1 (4.5) 2.6 (4.7) 1.7 (3.6) <0.0001
Data are meansSD or numbers (percentages). Scores are the sum of the individual points for each CVH metric and for each individual. A score of zero (0) indicates poor overall CVH, and
a score of 6 indicates ideal overall CVH. AHA indicates American Heart Association; CVH, cardiovascular health; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model
assessment of insulin resistance; hs-CRP, high-sensitivity C-reactive protein.
*Results are median (interquartile range).
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hemoglobin, markers of systemic inﬂammation (hs-CRP), and
insulin resistance (as measured by HOMA-IR). There were no
differences in family history of diabetes mellitus or sex
between categories.
Incident type 2 diabetes mellitus occurred in 492 persons
(rate, 24.6 per 1000 person-years) during a median follow-up
of 7.6 years (range, 3.5–12.2). Rates of diabetes mellitus
decreased across increasing categories of ideal CVH score
(Figure). Rates were highest among those with a score of 0
(30.8 events per 1000 person-years; 95% CI, 19.4–48.9) and
those with a score of 1 (30.2; 95% CI, 26.4–34.5). Rates
among those with scores of 2 and 3 were (24.0; 95% CI, 20.9–
27.7) and (17.1; 95% CI, 13.2–22.3), respectively. The lowest
rate was observed among those with an ideal CVH score of 4
or more (10.2; 95% CI, 5.5–18.9).
Multivariable Analysis
The HR of incident diabetes mellitus per each additional ideal
CVH metric in the unadjusted model was 0.77 (95% CI, 0.69–
0.85; Table 2). The HR for incident diabetes mellitus was
mildly attenuated, but remained signiﬁcant after adjustment
for age, sex, education, and income (HR, 0.80; 95% CI, 0.71–
0.90) and for hs-CRP (HR, 0.83; 95% CI, 0.74–0.93). With
additional adjustment for HOMA-IR (HR, 0.89; 95% CI, 0.79–
1.00), the association was no longer signiﬁcant.
We examined the association between ideal CVH summary
score and incident diabetes mellitus across categories of the
score (Table 3): score ≤1, score=2, and score ≥3. In the
unadjusted model, compared with participants with 1 or no
CVH metric (reference category, score ≤1), the HR for incident
diabetes mellitus was 0.82 (95% CI, 0.67–0.99) for those with
a score of 2, and 0.51 (95% CI, 0.39–0.68) for those with a
score ≥3 (P for trend, <0.0001). The HR for incident diabetes
mellitus for those with a score ≥3 was 0.58 (95% CI, 0.43–
0.77; P for trend, <0.001) when adjusted for age, sex,
education, and income and 0.63 (95% CI, 0.47–0.85; P for
trend=0.002) when further adjusted for hs-CRP. The associ-
ation was no longer signiﬁcant when adjusted for HOMA-IR
(HR, 0.74; 95% CI, 0.55–0.99; P for trend=0.06).
We did not formally test for mediation effects of HOMA-IR.
However, when only HOMA-IR was added to the unadjusted
model with ideal CVH score modeled as a continuous variable
(Table 2), there was a substantial decrease in the HR for
incident diabetes mellitus, from HR 0.77 (CI, 0.69–0.85) to HR
0.85 (CI, 0.76–0.94). Similarly, when only HOMA-IR was added
to the model containing categorical ideal CVH score (Table 3),
the HR decreased from 0.51 (CI, 0.39–0.68) to 0.64 (CI, 0.49–
0.84) for those with a score ≥3. These represented similar
magnitudes in attenuation of effects compared to when both
demographic factors and hs-CRP were adjusted for.
The association between ideal CVH and incident diabetes
mellitus was modiﬁed by central obesity (measured by waist
circumference; Pinteraction<0.001 in the demographic model). We
stratiﬁed our analysis by the median waist circumference
(98.0 cm). Compared with the upper median of waist
Figure. Crude rates (per 1000 person-years) of incident diabetes mellitus across
categories of the American Heart Association cardiovascular health summary score. Error
bars represent the 95% CIs about the rates. AHA indicates American Heart Association.
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circumference, the lower median had signiﬁcantly higher
proportions of participants with ideal BMI (28.6% versus 0.7%),
ideal BP (21.4% versus 10.5%), and ideal PA level (24.1% versus
18.6%; Table 4). There were no differences in ideal diet and ideal
total cholesterol between these 2 groups. In analysis adjusted
for age, sex, education, income, and hs-CRP, among participants
in the lower median of waist circumference, increasing ideal
CVH score was signiﬁcantly associated with a 21% decrease in
risk of incident diabetes mellitus (HR, 0.79; 95% CI, 0.66–0.97;
Table 5). Accounting for the effects of HOMA-IR attenuated this
relationship (HR, 0.83; 95% CI, 0.68–1.02). Among participants
in the upper median, there was no association between ideal
CVH score and incident diabetesmellitus even in the unadjusted
model (HR, 0.96; 95% CI, 0.84–1.10).
Association Between Individual Ideal CVH Metrics
and Diabetes Mellitus
Table S1 displays the results of multivariable analysis for each
individual CVH metric with incident diabetes mellitus. Only
BMI and BP were associated with diabetes mellitus after
adjustment for demographic factors and hs-CRP. The asso-
ciation between ideal PA and diabetes mellitus was signiﬁcant
in the unadjusted model, but this association was totally
explained by age, sex, education, and income. Smoking
status, total cholesterol, and diet were not associated with
diabetes mellitus.
Number Needed to Prevent
Based on a 5-year risk, we estimated the number of
participants who need to have increments of the ideal CVH
score in order to prevent 1 case of incident diabetes mellitus.
In the unadjusted model, compared to participants with no
ideal CVH metric, the number of participants needed to have
1, 2, 3, and ≥4 ideal CVH metrics to prevent 1 case of incident
diabetes mellitus were 167, 56, 29, and 20, respectively. After
accounting for age, sex, education, income, hs-CRP, and
HOMA-IR, the number of participants needed to have 1, 2, 3,
and ≥4 ideal CVH metrics to prevent 1 case of incident
diabetes mellitus were 279, 156, 55, and 49, respectively.
Discussion
In this contemporary middle-aged black cohort, we found that
the AHA-deﬁned ideal CVH metrics for CVD and stroke
prevention are associated with a decreased risk of incident
type 2 diabetes mellitus. Speciﬁcally, the risk of developing
diabetes mellitus decreased by 17% for each additional
baseline ideal CVH metric that a participant had, and
participants with at least 3 CVH metrics had a 37% risk
reduction, after accounting for demographic risk factors and
systemic inﬂammation. Our ﬁndings also suggest that the
association between the ideal CVH metrics and incident
diabetes mellitus is, in large part, explained by insulin
resistance (measured by HOMA-IR) and may differ according
Table 2. Unadjusted and Adjusted HRs and 95% CIs for
Incident Diabetes Mellitus Per Unit Increase in the AHA CVH
Score
Model HR 95% CI P Value
CVH score 0.77 0.69 to 0.85 <0.0001
CVH score+demographic factors* 0.80 0.71 to 0.90 <0.001
CVH score+demographic
factors+hs-CRP
0.83 0.74 to 0.93 0.002
CVH score+demographic
factors+Hs-CRP+HOMA-IR
0.89 0.79 to 1.00 0.06
CVH Score+HOMA-IR 0.85 0.76 to 0.94 0.002
AHA indicates American Heart Association; CVH, cardiovascular health; HOMA-IR,
homeostasis model assessment for insulin resistance; HR, hazard ratio; hs-CRP, high-
sensitivity C-reactive protein.
*Demographic factors include age, sex, education, and income.
Table 3. Unadjusted and Adjusted HRs and 95% CIs for Incident Diabetes Mellitus by Category of the AHA CVH Score
Models
Categories of AHA CVH Score
P TrendScore ≤1 HR (95% CI) Score=2 HR (95% CI) Score ≥3 HR (95% CI)
N/events 1042/235 1065/191 561/66
CVH score 1.0 0.82 (0.67–0.99) 0.51 (0.39–0.68) <0.0001
CVH score+demographic factors* 1.0 0.83 (0.68–1.02) 0.58 (0.43–0.77) <0.001
CVH score+demographic factors+hs-CRP 1.0 0.85 (0.69–1.04) 0.63 (0.47–0.85) 0.002
CVH score+demographic factors+hs-CRP+HOMA-IR 1.0 0.95 (0.77–1.17) 0.74 (0.55–0.99) 0.06
CVH score+HOMA-IR 1.0 0.92 (0.76–1.11) 0.64 (0.49–0.84) 0.003
AHA indicates American Heart Association; CVH, cardiovascular health; HOMA-IR, homeostasis model assessment for insulin resistance; HR, hazard ratio; hs-CRP, high-sensitivity
C-reactive protein.
*Demographic factors include age, sex, education, and income.
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to a participant’s waist circumference. Our ﬁndings differ from
those in the MESA study, in which the association was less
robust among blacks. The MESA study did not take into
account the effects of systemic inﬂammation and insulin
resistance, which we found to play a signiﬁcant role in the
association between ideal CVH and incident diabetes mellitus.
The prevalence of ideal CVH in our sample was very low.
No participant met all 6 ideal CVH goals and less than 1% of
them met 5 of the goals used in our analyses. Three quarters
of participants met only 1 or 2 ideal CVH metrics goals.
Previous studies have reported lower prevalence values
especially for persons with 1 or 2 ideal CVH metrics.7,25–27
Folsom et al, using data from the ARIC study,9 reported that
around 54% of black men and 55% of black women had
between 1 and 2 ideal CVH metrics. Prevalence values in our
study may be higher because of the fact that we used 6 of the
7 CVH metrics in deﬁning ideal health. A previous report from
the JHS cohort, using all 7 CVH metrics, showed a prevalence
of around 56% among those with 1 or 2 ideal CVH metrics,
similar to previous studies.8
Our ﬁndings support a protective role of ideal CVH, as
deﬁned by the AHA, on diabetes mellitus risk among blacks
and are consistent with previous reports on this association in
other populations using data from the SHFS10 and MESA.11 In
the SHFS, a lower odds of developing diabetes mellitus was
reported among American Indians who met at least 2 of the
ideal CVH goals, compared with those who met only 1 ideal
CVH goal or none. In MESA, an interaction by race/ethnicity
was found. Ideal CVH was associated with incident diabetes
mellitus in the general MESA study population, but when
stratiﬁed by race/ethnicity, the association was less robust
among blacks and Hispanics compared with whites and
Chinese. Findings from our study showed that the association
between ideal CVH and incident diabetes mellitus is, in fact,
robust and consistent among blacks and independent of age,
sex, socioeconomic status, and the presence of systemic
inﬂammation. The magnitude of risk reduction differs across
studies; compared with our study where participants with 3 or
more ideal CVH metrics had a 37% reduction in risk of
diabetes mellitus, in the SHFS and in MESA, American Indians,
Table 4. Ideal CVH Metrics by Median Waist Circumference
CVH Metric Median WC <98.0 cm Median WC ≥98.0 cm P Value
Ideal CVH score 2.11.0 1.60.8 <0.0001
Categories ideal CVH score, n (%) <0.0001
≤1 406 (30.7) 636 (47.2)
2 523 (39.6) 542 (40.2)
≥3 392 (29.7) 169 (12.6)
AHA body mass index category, n (%) <0.0001
Not ideal, ≥25 kg/m2 943 (71.4) 1338 (99.3)
Ideal, <25 kg/m2 378 (28.6) 9 (0.7)
AHA blood pressure category, n (%) <0.0001
Not ideal, ≥120/ or ≥80 mm Hg 1038 (78.6) 1206 (89.5)
Ideal, <120/<80 mm Hg without treatment 283 (21.4) 141 (10.5)
AHA total cholesterol category, n (%) 0.45
Not ideal, ≥200 mg/dL 742 (56.2) 776 (57.6)
Ideal, <200 mg/dL without treatment 579 (43.8) 571 (42.4)
AHA diet category, n (%) 0.079
Not ideal, <4 components 1306 (98.9) 1340 (99.5)
Ideal, 4 to 5 components 15 (1.1) 7 (0.5)
AHA smoking category, n (%) 0.024
Not ideal, current or former smoker or quit less ≤12 months ago 169 (12.8) 135 (10.0)
Ideal, never smoker or quit >12 months ago 1152 (87.2) 1212 (90.0)
AHA physical activity category, n (%) <0.001
Not ideal, none or <150 mod. or <75 vig. or <150 mod. +vig. 1002 (75.9) 1096 (81.4)
Ideal, ≥150 mod. or ≥75 vig. or ≥150 mod. +vig. 319 (24.1) 251 (18.6)
Data for ideal CVH score are presented as meanSD. AHA indicates American Heart Association; CVH, cardiovascular health.
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non-Hispanic whites, and Chinese Americans with 4 or more
ideal CVH metrics had an 89%, 87%, and 88% reduction in risk,
respectively. These differences may be explained, in part, by
differences in methodology across studies, but may also
reﬂect potential race/ethnic differences in the association
between ideal CVH and incident diabetes mellitus. In recent
genetic studies, single-nucleotide polymorphism variants in
the APOE locus, which has been associated with clinical ideal
CVH,28 were found to be associated with multiple compo-
nents of metabolic syndrome in blacks.29
When the CVH metrics were considered individually, the
association between ideal CVH and incident diabetes mellitus
appeared to be driven primarily by BMI, which could explain
why insulin resistance plays a signiﬁcant role in the associ-
ation. There were no apparent PA/diabetes mellitus, diet/
diabetes mellitus, smoking/diabetes mellitus, and total
cholesterol/diabetes mellitus associations. Similar ﬁndings
were reported in the SHFS and MESA.10,11 Given that less
than 1% of our participants met the dietary targets for ideal
CVH, we had limited power to adequately examine the
association between diet and diabetes mellitus. As such, our
results for healthy diet need to be interpreted with caution.
The effects of diet and PA may not have been adequately
captured in our sample by questionnaires, and their true
effects may not be independent of BMI. There is evidence that
adherence to the Dietary Approach to Stop Hypertension diet
reduces insulin resistance30 and the risk of incident diabetes
mellitus.31 Although only 2 (BMI and BP) of 6 CVH metrics
were individually associated with diabetes mellitus risk, the
ﬁnding of a signiﬁcant trend in the association between
categories of the CVH score (0–1, 2, and 3+) and incident
diabetes mellitus suggests that the beneﬁcial effects of the
CVH metrics on diabetes mellitus risk is synergistic and
cumulative. In fact, when compared with those with 0 to 1
ideal CVH metric, having 3 or more ideal CVH metrics was
associated with a 37% reduction in diabetes mellitus risk.
Other risk factors taken into account, 55 people in the
population would need to meet 3 AHA ideal CVH targets to
prevent 1 case of diabetes mellitus, and 49 people would
need to meet 4 or more AHA ideal CVH targets to prevent 1
case of diabetes mellitus.
Our results suggest that less-than-ideal levels of AHA CVH
may reﬂect a state of insulin resistance, which would promote
the occurrence of not only diabetes mellitus, but also probably
of CVDs. Although there was no apparent association
between ideal PA and ideal diet with incident diabetes
mellitus in our analysis, both have been associated with a
reduction in diabetes mellitus risk in previous studies.32–35
Data from the Diabetes Prevention Program showed that
weight loss achieved through PA and a healthy low-fat, low-
calorie diet reduced the incidence of diabetes mellitus by 61%
in blacks, when compared with placebo.5 Diabetes mellitus
risk reduction was greatest in the lifestyle group, compared
with the other groups. The reduction in diabetes mellitus risk
is thought to be mediated by improvements in insulin
sensitivity, as a result of weight loss and PA. Although there
were no differences in CVD events (myocardial infarction,
stroke, and coronary revascularization) after 3 years between
treatment arms in the Diabetes Prevention Program, there
were signiﬁcant reductions in cardiometabolic risk factors in
the lifestyle arm, including high triglyceride levels, hyperten-
sion, low high-density lipoprotein, and small dense low-density
lipoprotein.36 In other clinical trials with longer durations of
follow-up, such cardiometabolic risk factor reductions have
Table 5. Unadjusted and Adjusted HRs and 95% CIs for Incident Diabetes Mellitus Per Unit Increase in the AHA CVH Score,
Stratiﬁed by Median WC
Model Hazard Ratio 95% CI P Value
Waist circumference <98.0 cm 0.67 0.57 to 0.82 <0.0001
CVH score 0.75 0.62 to 0.92 0.006
CVH score+demographic factors* 0.79 0.66 to 0.97 0.022
CVH score+demographic factors+hs-CRP 0.83 0.68 to 1.02 0.081
CVH score+demographic factors+hs-CRP+HOMA-IR 0.67 0.57 to 0.82 <0.0001
Waist circumference ≥98.0 cm 0.96 0.84 to 1.10 0.56
CVH score 0.97 0.84 to 1.13 0.71
CVH score+demographic factors 0.97 0.84 to 1.13 0.70
CVH score+demographic factors+hs-CRP 1.01 0.87 to 1.17 0.92
CVH score+demographic factors+hs-CRP+HOMA-IR 0.96 0.84 to 1.10 0.56
P interaction, <0.001 in demographic model. CVH indicates cardiovascular health; HOMA-IR, homeostasis model assessment for insulin resistance; HR, hazard ratio; hs-CRP, high-
sensitivity C-reactive protein; WC, waist circumference.
*Demographic factors include age, sex, education, and income.
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resulted in reductions in both fatal and nonfatal CVD
events.37,38
The association between CVH metrics and diabetes
mellitus differed according to waist circumference levels.
The ﬁnding of a signiﬁcant association among participants in
the lower median of waist circumference, but not among
those in the upper median, may simply reﬂect a greater
heterogeneity in the distribution of ideal CVH metrics as
indicated by the differences observed in the proportions of
ideal CVH between participants in the lower and upper
median of waist circumference. This pattern warrants further
investigation and replication in other cohorts.
The strengths of our analysis include the use of a sizable
cohort of blacks with more incident diabetes mellitus events
compared to previous reports in the same population.11 Not
only were we able to more robustly assess the extent of the
associations between ideal CVH and diabetes mellitus, we
also conducted a more comprehensive ascertainment of
diabetes mellitus (using the American Diabetes Association
2010 criteria, including HbA1c level), thus reducing the
potential for misclassiﬁcations. Furthermore, in contrast to
previous studies, we explored the potential role of insulin
resistance, measured by HOMA-IR, on the observed associ-
ation between CVH metrics and diabetes mellitus. Some
limitations of the present study should be addressed. Because
of the small number of participants and events for some CVH
metrics (diet and smoking), we were unable to fully explore
the individual effects of these health behaviors on incident
diabetes mellitus. Also, it is difﬁcult to assess the true
independent effects of inter-related parameters such as BMI,
PA, diet, BP, and HOMA-IR. In addition, although validated
instruments were used in the JHS to measure PA39 and diet,40
an association between PA and diet with diabetes mellitus
may not have been apparent owing to the self-reported nature
of these measures. Because some of the CVH metrics were
self-reported (PA, diet, and smoking), residual confounding
could be present. Time to incident diabetes mellitus was
interval-censored and the midpoint between 2 study visits
was imputed as the time to incident diabetes mellitus. This
approach of imputing time to event has been validated in
previous studies.41,42
Conclusion
Our study showed that each additional ideal AHA CVH metric
was associated with a 17% reduction in the risk of incident
diabetes mellitus in blacks, after accounting for demographic
factors and systemic inﬂammation. The association between
the ideal CVH metrics and incident diabetes mellitus may be
synergistic and cumulative and was largely explained by
insulin resistance. These data support the application the
concept of ideal CVH as deﬁned by the AHA in diabetes
mellitus prevention in this population.
Implications
Our ﬁndings, which support a protective role of ideal CVH
metrics (healthy BMI, healthy diet, nonsmoking status, normal
total cholesterol, normal BP, and PA) have implications from a
primary prevention standpoint. The overall low prevalence of
higher levels of ideal CVH, as deﬁned by the AHA, among
blacks is alarming and calls for targeted public health
interventions to improve on disparities for CVD and diabetes
mellitus among blacks, a population that is disproportionately
affected by these 2 conditions.
Our study has shown that if people meet increasing targets
of AHA ideal CVH metrics, diabetes mellitus can be prevented.
It would need 55 people in the population to meet 3 AHA ideal
CVH targets to prevent 1 case of diabetes mellitus and 49
people to meet 4 or more AHA ideal CVH targets to prevent 1
case of diabetes mellitus. Interventions with a primary focus
of improving health behaviors so that more blacks achieve the
AHA targets for ideal CVH are important and may have a
signiﬁcant impact in reducing diabetes mellitus risk. Our
ﬁndings suggest that the effects of these ideal CVH metrics
may be cumulative and synergistic. In this light, future lifestyle
or behavioral interventions should take into account as many
AHA ideal CVH metrics as possible, and not just 1 particular
metric, to potentially increase the impact of the interventions
on reducing diabetes mellitus risk. Also, future joint efforts for
CVD and diabetes mellitus prevention among blacks may
provide 1 effective and cost-efﬁcient strategy for public health
experts and policy makers to tackle the growing challenge of
diabetes mellitus and CVD.
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SUPPLEMENTAL MATERIAL 
 
Table S1. Unadjusted and Adjusted Hazard Ratios and 95% Confidence Intervals for Incident Diabetes for each Individual American 
Heart Association Cardiovascular Health Metric. 
Cardiovascular Health Metric N/events Model 1 Model 2 Model 3 Model 4 
  Hazard Ratio (95% Confidence interval) 
Body Mass Index, kg/m2      
    Poor, ≥ 30 1,365/336 1.0 1.0 1.0 1.0 
    Intermediate, 25 – 29.9 916/126 0.55 (0.44 – 0.67) 0.50 (0.40 – 0.63) 0.54 (0.43 – 0.69) 0.76 (0.60 – 0.96) 
    Ideal, < 25 387/30 0.30 (0.20 – 0.44) 0.29 (0.19 – 0.43) 0.32 (0.22 – 0.49) 0.58 (0.38 – 0.88) 
Blood Pressure, mmHg      
    Poor, ≥ 140 / or ≥ 90 358/77 1.0 1.0 1.0 1.0 
    Intermediate, 120-139 / or 80-89 or <120/< 80 with treatment 1,886/369 0.94 (0.74 – 1.21) 0.90 (0.69 – 1.17) 0.91 (0.69 – 1.18) 0.95 (0.73 – 1.24) 
    Ideal, < 120/< 80 without treatment  424/46 0.51 (0.35 – 0.73) 0.56 (0.37 – 0.84) 0.58 (0.39 – 0.87) 0.72 (0.48 – 1.08) 
Total Cholesterol, mg/dl      
    Poor, ≥ 240 411/90 1.0 1.0 1.0 1.0 
    Intermediate, 200 – 239 or < 200 with treatment 1,107/200 0.87 (0.68 – 1.12) 0.90 (0.68 – 1.17) 0.89 (0.68 – 1.17) 0.94 (0.71 – 1.23) 
    Ideal, < 200 without treatment 1,150/202 0.83 (0.65 – 1.06) 0.88 (0.67 – 1.15) 0.86 (0.65 – 1.12) 0.92 (0.70 – 1.20) 
Dietary Measures      
    Poor, 0-1 component 1,644/306 1.0 1.0 1.0 1.0 
    Intermediate, 2-3 components 1,002/183 1.08 (0.90 – 1.30) 1.15 (0.94 – 1.40) 1.14 (0.93 – 1.39) 1.15 (0.94 – 1.40) 
    Ideal, 4-5 components 22/3 N/A N/A N/A N/A 
Smoking      
    Poor, current smoker 284/54 1.0 1.0 1.0 1.0 
    Intermediate, former smoker or quit less ≤ 12 months ago 20/3 N/A N/A N/A N/A 
    Ideal, never smoker  or quit less >12 months ago 2,364/435 1.04 (0.78 – 1.38) 1.08 (0.79 – 1.47) 1.13 (0.83 – 1.55) 0.93 (0.69 – 1.28) 
Physical Activity, minutes/week      
    Poor, None 1,203/240 1.0 1.0 1.0 1.0 
    Intermediate, < 150 mod. or < 75 vig. or < 150 mod. + vig. 895/161 0.85 (0.69 – 1.04) 0.88 (0.71 – 1.10) 0.90 (0.72 – 1.13) 0.94 (0.75 – 1.18) 
    Ideal, ≥ 150 mod. or ≥ 75 vig. or ≥ 150 mod. + vig. 570/91 0.78 (0.61 – 0.99) 0.82 (0.63 – 1.07) 0.85 (0.65 – 1.11) 0.92 (0.70 – 1.20) 
      
 
Model 1: unadjusted. Model 2: model 1, age, sex, education and income. Model 3: model 2, high-sensitivity C-reactive protein. Model 4: model 3, 
HOMA-IR. Mod. indicates moderate; vig., vigorous. Dietary components: Fruits and vegetables: ≥4.5 cups per day; Fish: ≥two 3.5-oz servings per 
week; Fiber-rich whole grains (≥1.1 g of fiber per 10 g of carbohydrate): ≥three 1-oz-equivalent servings per day; Sodium: <1500 mg per day; 
Sugar-sweetened beverages: ≤450 kcal (36 oz) per week. 
